Cargando…
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3). Both joint and meta-analysis analysis approaches were...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090745/ https://www.ncbi.nlm.nih.gov/pubmed/21460841 http://dx.doi.org/10.1038/ng.801 |
Sumario: | The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study (GWAS) of late-onset Alzheimer disease (LOAD) using a 3 stage design consisting of a discovery stage (Stage 1) and two replication stages (Stages 2 and 3). Both joint and meta-analysis analysis approaches were used. We obtained genome-wide significant results at MS4A4A [rs4938933; Stages 1+2, meta-analysis (P(M)) = 1.7 × 10(−9), joint analysis (P(J)) = 1.7 × 10(−9;) Stages 1–3, P(M) = 8.2 × 10(−12)], CD2AP (rs9349407; Stages 1–3, P(M) = 8.6 × 10(−9)), EPHA1 (rs11767557; Stages 1–3 P(M) = 6.0 × 10(−10)), and CD33 (rs3865444; Stages 1–3, P(M) = 1.6 × 10(−9)). We confirmed that CR1 (rs6701713; P(M) = 4.6×10(−10), P(J) = 5.2×10(−11)), CLU (rs1532278; P(M) = 8.3 × 10(−8), P(J) = 1.9×10(−8)), BIN1 (rs7561528; P(M) = 4.0×10(−14); P(J) = 5.2×10(−14)), and PICALM (rs561655; P(M) = 7.0 × 10(−11), P(J) = 1.0×10(−10)) but not EXOC3L2 are LOAD risk loci(1–3). |
---|